menu
    • menu

    Company profile for Aceragen

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aceragen is a rare disease biopharmaceutical company. We address rare, orphan diseases that typically have no available treatment, and strive to develop novel therapies which can have a positive impact on the lives of patients and families. As such, the needs of the patients who suffer from neglected rare diseases drive our mission first and foremost. Our goal is to provide rare disease patients with compelling new therapeutic...
    Aceragen is a rare disease biopharmaceutical company. We address rare, orphan diseases that typically have no available treatment, and strive to develop novel therapies which can have a positive impact on the lives of patients and families. As such, the needs of the patients who suffer from neglected rare diseases drive our mission first and foremost. Our goal is to provide rare disease patients with compelling new therapeutic options that will allow them to lead the fullest lives possible. By focusing on rare and orphan diseases, we hope to bring a much-needed spotlight to the area by leveraging our collective conviction.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AceragenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    15 TW Alexander Drive Durham, NC 27709
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aceragen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aceragen/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aceragen, Inc. to Delist from The Nasdaq Stock Market
    Aceragen, Inc. to Delist from The Nasdaq Stock Market

    04 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/04/2719284/33448/en/Aceragen-Inc-to-Delist-from-The-Nasdaq-Stock-Market.html

    GLOBENEWSWIRE
    04 Aug 2023
    Share Share
    Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
    Aceragen, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing

    30 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/30/2678854/33448/en/Aceragen-Inc-Receives-Nasdaq-Notice-Regarding-Delayed-Form-10-Q-Filing.html

    GLOBENEWSWIRE
    30 May 2023
    Share Share
    Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study
    Aceragen Announces Recommendation of Data Monitoring Committee in Terra Study

    06 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/06/2602192/33448/en/Aceragen-Announces-Recommendation-of-Data-Monitoring-Committee-in-Terra-Study.html

    GLOBENEWSWIRE
    06 Feb 2023
    Share Share
    Aeterna discontinues vaccine development; Idera rebrands as Aceragen
    Aeterna discontinues vaccine development; Idera rebrands as Aceragen

    17 Jan 2023

    // Paul Schloesser ENDPTS

    https://endpts.com/aeterna-discontinues-vaccine-development-idera-rebrands-as-aceragen/

    Paul Schloesser ENDPTS
    17 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search